Study supports practice expense hikes for cancer care

Article Overview

This article examines evidence suggesting that Medicare practice expense payments for oncology services may be below actual costs, based on a survey analysis funded by cancer-care stakeholders and reviewed by Medicare officials. It discusses the policy and budget implications for oncology practices, the role of CMS, and the broader debate over how payment changes could be financed within the Medicare physician fee schedule. The piece is relevant to oncology practices, billing and reimbursement professionals, and others tracking physician payment policy.